These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31124015)

  • 1. CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome.
    Wang Z; Yang L; Qu S; Zhang C
    Protein Cell; 2019 Oct; 10(10):705-708. PubMed ID: 31124015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
    Wang YD; Liang QF; Li ZY; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 6. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing: The efficient tool CRISPR-Cpf1.
    Mahfouz MM
    Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
    [No Abstract]   [Full Text] [Related]  

  • 8. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.
    Li S; Zhang X; Wang W; Guo X; Wu Z; Du W; Zhao Y; Xia L
    Mol Plant; 2018 Jul; 11(7):995-998. PubMed ID: 29567453
    [No Abstract]   [Full Text] [Related]  

  • 10. CRISPR-Cas in its prime.
    Zlotorynski E
    Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
    [No Abstract]   [Full Text] [Related]  

  • 11. Include egg donors in CRISPR gene-editing debate.
    Niemiec E; Howard HC
    Nature; 2019 Nov; 575(7781):51. PubMed ID: 31690864
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.
    Stellos K; Musunuru K
    Cardiovasc Res; 2019 Feb; 115(2):e12-e14. PubMed ID: 30668679
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic engineering: Chemical control for CRISPR editing.
    Hilton IB; Gersbach CA
    Nat Chem Biol; 2017 Jan; 13(1):2-3. PubMed ID: 27820804
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
    Kim ST; Park J; Kim D; Kim K; Bae S; Schlesner M; Kim JS
    Nat Methods; 2018 Apr; 15(4):239-240. PubMed ID: 29600990
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
    Wilson CJ; Fennell T; Bothmer A; Maeder ML; Reyon D; Cotta-Ramusino C; Fernandez CA; Marco E; Barrera LA; Jayaram H; Albright CF; Cox GF; Church GM; Myer VE
    Nat Methods; 2018 Apr; 15(4):236-237. PubMed ID: 29600989
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
    Lescarbeau RM; Murray B; Barnes TM; Bermingham N
    Nat Methods; 2018 Apr; 15(4):237. PubMed ID: 29600988
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene Editing for the Heart: Correcting Dystrophin Mutations.
    McNally EM
    Circ Res; 2017 Sep; 121(8):896-898. PubMed ID: 28963182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation diagnostics with CRISPR.
    Chertow DS
    Science; 2018 Apr; 360(6387):381-382. PubMed ID: 29700254
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibiting CRISPR.
    Rusk N
    Nat Methods; 2019 Mar; 16(3):218. PubMed ID: 30814697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.